Realtime continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE, Diabetes Metab, vol.38, pp.67-83, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01930684
Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care, vol.32, pp.2245-50, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00448802
Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study, Diabetes Technol Ther, vol.18, issue.3, pp.127-162, 2016. ,
Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management, Diabetes Technol Ther, vol.18, issue.5, pp.288-91, 2016. ,
Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function, BMJ Open, vol.6, issue.4, p.11589, 2016. ,
Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications, vol.169, pp.1307-1323, 1983. ,
, The Diabetes Control and Complications Trial Research Group, Hypoglycemia in the Diabetes Control and Complications Trial, vol.46, pp.271-86, 1997.
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial, Diabetologia, vol.55, issue.12, pp.3155-62, 2012. ,
Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device), Health Qual Life Outcomes, vol.7, p.83, 2009. ,
Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures. Qual Life Res Int J Qual Life Asp Treat Care Rehabil, vol.20, pp.1513-1521, 2011. ,
Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study. Diabetes Care, vol.35, pp.965-71, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01930701
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia, J Diabetes Sci Technol, vol.7, issue.4, pp.1005-1015, 2013. ,
,
, Threshold-based insulin-pump interruption for reduction of hypoglycemia, N Engl J Med, vol.369, issue.3, pp.224-256, 2013.
Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care, vol.34, pp.795-800, 2011. ,
CostEffectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France, Diabetes Technol Ther, vol.18, issue.2, pp.75-84, 2016. ,
Validation of the CORE Diabetes Model against epidemiological and clinical studies, Curr Med Res Opin, issue.1, pp.27-40, 1920. ,
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making, Curr Med Res Opin, issue.1, pp.5-26, 1920. ,
Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop study, J Diabetes Sci Technol, vol.8, issue.6, pp.1177-84, 2014. ,
, Lorsque la glycémie est en-dessous de l'objectif : 2. Lorsque la glycémie est à l'objectif
Etiology of type 1 diabetes, Immunity. 23 avr, vol.32, issue.4, pp.457-67, 2010. ,
, Institut de veille sanitaire (France). Prévalence et incidence du diabète, et mortalité liée au diabète en France: synthèse épidémiologique, User S. IDF diabetes atlas-Across the globe, 2010.
, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med, vol.329, issue.14, pp.977-86, 1993.
When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM), Diabetes Metab. févr, vol.36, issue.1, pp.79-85, 2009. ,
DOI : 10.1016/j.diabet.2009.09.002
URL : https://hal.archives-ouvertes.fr/hal-00482959
Insulin pump therapy: a metaanalysis, Diabetes Care. avr, vol.26, issue.4, pp.1079-87, 2003. ,
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion, Diabet Med J Br Diabet Assoc. juill, vol.25, issue.7, pp.765-74, 2008. ,
Capteurs de glucose et mesure continue du glucose: Glucose sensor and continuous glucose measurement, Médecine Mal Métaboliques. mars, vol.4, issue.2, pp.157-68, 2010. ,
DOI : 10.1016/s1957-2557(10)70032-8
Is continuous glucose monitoring (CGM) for everyone? To whom should CGM be prescribed and how?, Diabetes Metab. déc, vol.37, issue.4, pp.80-84, 2011. ,
DOI : 10.1016/s1262-3636(11)70971-5
Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study, Diabetes Metab. juin, vol.34, issue.3, pp.219-245, 2001. ,
Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: metaanalysis of randomised controlled trials using individual patient data, BMJ, vol.343, p.3805, 2011. ,
Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study, Diabetes Care. mai, vol.35, issue.5, pp.965-71, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01930701
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes, N Engl J Med. 22 juill, vol.363, issue.4, pp.311-331, 2010. ,
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, vol.32, pp.1947-53, 2009. ,
Sensoraugmented insulin pump therapy: results of the first randomized treat-to-target study, Diabetes Technol Ther. oct, vol.10, issue.5, pp.377-83, 2008. ,
Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study, Diabetes Care. déc, vol.32, issue.12, pp.2245-50, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00448802
Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring, Diabetes Care. déc, vol.29, issue.12, pp.2730-2732, 2006. ,
DOI : 10.2337/dc06-1134
URL : http://care.diabetesjournals.org/content/diacare/29/12/2730.full.pdf
Continuous glucose monitoring and intensive treatment of type 1 diabetes, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, vol.359, pp.1464-76, 2008. ,
,
, Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial, Diabet Med J Br Diabet Assoc, vol.28, issue.10, pp.1158-67, 2011.
Sensor-augmented pump therapy at 36 months, Diabetes Technol Ther. déc, vol.14, issue.12, pp.1174-1181, 2012. ,
DOI : 10.1089/dia.2012.0148
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial, Diabetologia. déc, vol.55, issue.12, pp.3155-62, 2012. ,
The effect of continuous glucose monitoring in well-controlled type 1 diabetes, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, vol.32, pp.1378-83, 2009. ,
ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia, J Diabetes Sci Technol. juill, vol.7, issue.4, pp.1005-1015, 2013. ,
,
, Threshold-based insulin-pump interruption for reduction of hypoglycemia, N Engl J Med. 18 juill, vol.369, issue.3, pp.224-256, 2013.
Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes, Diabetes Care. avr, vol.34, issue.4, pp.795-800, 2011. ,
RealTime Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes, Diabetes Care. déc, vol.36, issue.12, pp.4160-4162, 2013. ,
Realtime continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE, Diabetes Metab. juill, vol.38, pp.67-83, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01930684
, Standards of Medical Care in Diabetes-2016: Summary of Revisions, Diabetes Care. janv, vol.39, issue.1, pp.4-5, 2016.
Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk, Diabetes Care. sept, vol.34, issue.9, pp.2023-2028, 2011. ,
Effect of sensoraugmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial, JAMA. 25 sept, vol.310, issue.12, pp.1240-1247, 2013. ,
Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose, Diabetes Care, vol.37, issue.3, pp.773-782, 2014. ,
Hypoglycemia Prevention and User Acceptance of an Insulin Pump System with Predictive Low Glucose Management, Diabetes Technol Ther. mai, vol.18, issue.5, pp.288-91, 2016. ,
Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function, BMJ Open, vol.6, issue.4, p.11589, 2016. ,
Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey, Expert Rev Pharmacoecon Outcomes Res. févr, vol.13, issue.1, pp.123-153, 2013. ,
Cost of Inpatient Management of Hypoglycaemia in France. Value Health, vol.16, p.436, 2013. ,
The burden and treatment of diabetes in France, Glob Health, vol.10, p.6, 2014. ,
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making, Curr Med Res Opin. août, vol.20, issue.1, pp.5-26, 2004. ,
A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus, PharmacoEconomics. juin, vol.34, issue.6, pp.569-85, 2016. ,
Validation of the CORE Diabetes Model against epidemiological and clinical studies, Curr Med Res Opin. août, vol.20, issue.1, pp.27-40, 2004. ,
Validation of the IMS CORE Diabetes Model, Value Health J Int Soc Pharmacoeconomics Outcomes Res. sept, vol.17, issue.6, pp.714-738, 2014. ,
Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes, Diabet Med. 1 mai, vol.32, issue.5, pp.618-644, 2015. ,
CostEffectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France, Diabetes Technol Ther. févr, vol.18, issue.2, pp.75-84, 2016. ,
Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study, Diabetes Technol Ther. mars, vol.18, issue.3, pp.127-162, 2016. ,
Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy, Diabetes Care. juill, vol.35, issue.7, pp.1462-1467, 2012. ,
Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures, Qual Life Res, vol.20, issue.9, pp.1513-1521, 2011. ,
Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device), Health Qual Life Outcomes. 9 sept, vol.7, p.83, 2009. ,
Feasibility of automating insulin delivery for the treatment of type 1 diabetes, Diabetes. déc, vol.55, issue.12, pp.3344-50, 2006. ,
Closed-loop insulin delivery for treatment of type 1 diabetes, BMC Med, vol.9, p.120, 2011. ,
Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop study, J Diabetes Sci Technol, vol.8, issue.6, 2014. ,